No Image Provided

Eagle Genomics

VC Funding

Series A

DeepTech & AI Healthcare & Biotech Published 1 November 2022

Summary

In a significant market movement during November 2022, Eagle Genomics was the subject of a vc funding. The transaction achieved a gross valuation of £17,303,308. Leading the round was abrdn plc, Environmental Technologies Fund, Granpool Innovative Investments.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

abrdn plc

Lead Investor / Acquirer

Environmental Technologies Fund

Lead Investor / Acquirer

Granpool Innovative Investments

Advising Broker

Undisclosed Firm

Related Deals in DeepTech & AI / Healthcare & Biotech

Series A prioritised

VC Funding

Techspert.io

£8,809,481

Oct 2021

VC Funding

Exscientia

£35,000,000

Sept 2021

VC Funding

Eagle Genomics

£6,889,296

Oct 2020

VC Funding

Techspert.io

£3,760,000

Feb 2020

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.